This page has beta status

CMST COST Action D39
Metallo-Drug Design and Action

The main objective of the Action is to increase knowledge and understanding of the design and mechanisms of actions of metallo-drugs, and to use this enhanced knowledge in combination with modern genomic research to develop new classes of metallo-drugs with truly novel mechanisms of action and novel spectra of biomedical activity.

(Descriptions are provided by the Actions directly via e-COST.)

General Information*

Chair of the Action:

Prof Viktor BRABEC (CZ)

Vice Chair of the Action:

Prof Dan GIBSON (IL)

Science officer of the Action:

Dr Lucia FORZI

Administrative officer of the Action:

Ms Svetlana VOINOVA


Action Fact Sheet

Download AFS as .RTF

Memorandum of Understanding

Download MoU as PDF

Progress Report

Download Progress Report as PDF


Download Poster as PDF


Last updated: 02 May 2011 top of page